izpis_h1_title_alt

Progression of coronary calcium burden and carotid stiffness in patients with essential thrombocythemia associated with JAK2 V617F mutation
ID Anžič Drofenik, Ajda (Author), ID Vrtovec, Matjaž (Author), ID Božič, Mojca (Author), ID Sever, Matjaž (Author), ID Preložnik-Zupan, Irena (Author), ID Kejžar, Nataša (Author), ID Blinc, Aleš (Author)

.pdfPDF - Presentation file, Download (613,23 KB)
MD5: 971869609BF7850F3F17F3E103561E6B
URLURL - Source URL, Visit https://www.sciencedirect.com/science/article/pii/S0021915020300162 This link opens in a new window

Abstract
Background and aims: Patients with myeloproliferative neoplasms often succumb to cardiovascular events, but little is known on the early stages of their vascular disease. We studied how patients with JAK2 V617F positive essential thrombocythemia (ET) without overt atherosclerotic disease differed from control subjects in the progression of carotid artery stiffness and preclinical atherosclerosis. Methods: Thirty-six patients with JAK2 V617F positive ET and 38 age-, gender- and Framingham coronary heart disease (CHD) -matched control subjects were examined twice within 4 years. Clinical and laboratory testing, echo-tracking ultrasound of carotid arteries, coronary calcium measurement and digital plethysmography were performed (ClinTrials.gov NCT03828422). Results: Coronary calcium correlated with the Framingham CHD risk score at the first examination in the control group (r$_s$ = 0.410), but not among the ET patients (r$_s$ = 0.116). Both groups progressed in coronary calcium, but the outliers were more prominent among ET patients. Carotid artery stiffness increased with time in the ET patients much more than in the control group: the increase in β-index 1.95 (SD 2.18) vs. 0.22 (SD 1.99), p < 0.001, and the increase in carotid pulse wave velocity 0.72 (SD 0.92) vs. 0.08 (SD 0.72) m/s, p = 0.001. There was no correlation between carotid stiffness and Framingham CHD risk in either group. Digital endothelial function did not change. Conclusion: Carotid artery stiffness progressed faster in patients with JAK2 V617F positive ET than in control subjects. Coronary calcium correlated with the Framingham CHD risk only in control subjects. This indicates that JAK2 V617F positive ET acted as a non-classical risk factor for vascular disease.

Language:English
Keywords:essential thrombocythemia, JAK2 V617F mutation, arterial stiffness, coronary calcium, cardiovascular risk
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:MF - Faculty of Medicine
Publication status:Published
Publication version:Version of Record
Year:2020
Number of pages:Str. 25-31
Numbering:Vol. 296
PID:20.500.12556/RUL-137781 This link opens in a new window
UDC:616.1
ISSN on article:0021-9150
DOI:10.1016/j.atherosclerosis.2020.01.001 This link opens in a new window
COBISS.SI-ID:6959276 This link opens in a new window
Publication date in RUL:30.06.2022
Views:396
Downloads:78
Metadata:XML RDF-CHPDL DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Atherosclerosis
Shortened title:Atherosclerosis
Publisher:Elsevier
ISSN:0021-9150
COBISS.SI-ID:25033216 This link opens in a new window

Licences

License:CC BY-NC-ND 4.0, Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
Link:http://creativecommons.org/licenses/by-nc-nd/4.0/
Description:The most restrictive Creative Commons license. This only allows people to download and share the work for no commercial gain and for no other purposes.

Projects

Funder:ARRS - Slovenian Research Agency
Project number:P3-0308
Name:Ateroskleroza in tromboza

Funder:ARRS - Slovenian Research Agency
Project number:P3-0154
Name:Metodologija za analizo podatkov v medicini

Funder:Other - Other funder or multiple funders
Funding programme:University Medical Centre Ljubljana
Project number:20180038

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back